Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Receptor Status and Ethnicity of Indigent Patients With Breast Cancer in New York City

Receptor Status and Ethnicity of Indigent Patients With Breast Cancer in New York City RESIDENT’S FORUM SECTION EDITORS: RICHARD D. SCHULICK, MD; PAMELA A. LIPSETT, MD Receptor Status and Ethnicity of Indigent Patients With Breast Cancer in New York City Jennifer L. Marti, MD; Amber Guth, MD; Arpana Naik, MD; Karen L. Hiotis, MD revious studies have suggested racial differences in breast cancer hormonal receptor sta- tus, reflecting possible differences in tumor biology. However, racial differences in so- cioeconomic status and reproductive risk factors may influence receptor status. We in- P vestigated this issue, studying a racially diverse but socioeconomically homogeneous cohort of 215 patients with breast cancer at a New York public hospital from January 1, 1999, through December 31, 2003. We analyzed positive findings for estrogen, progesterone, and human epider- mal growth factor receptor 2 (HER2) (HER2/neu) receptors, considering patients in racial groups by cancer stage and overall. No difference was found in rates of estrogen, progesterone, or HER2/ neu positivity among Asian, black, Hispanic, or white patients presenting with ductal carcinoma in situ or with invasive cancer. Arch Surg. 2008;143(12):1227-1230 These patients represented all surgical pa- Breast cancer constitutes 18% of cancers tients with complete receptor data available. in women and is the second leading cause Rates of positivity for http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Surgery American Medical Association

Receptor Status and Ethnicity of Indigent Patients With Breast Cancer in New York City

Loading next page...
 
/lp/american-medical-association/receptor-status-and-ethnicity-of-indigent-patients-with-breast-cancer-bGJysfnznI
Publisher
American Medical Association
Copyright
Copyright 2008 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6254
eISSN
2168-6262
DOI
10.1001/archsurg.143.12.1227
pmid
19075177
Publisher site
See Article on Publisher Site

Abstract

RESIDENT’S FORUM SECTION EDITORS: RICHARD D. SCHULICK, MD; PAMELA A. LIPSETT, MD Receptor Status and Ethnicity of Indigent Patients With Breast Cancer in New York City Jennifer L. Marti, MD; Amber Guth, MD; Arpana Naik, MD; Karen L. Hiotis, MD revious studies have suggested racial differences in breast cancer hormonal receptor sta- tus, reflecting possible differences in tumor biology. However, racial differences in so- cioeconomic status and reproductive risk factors may influence receptor status. We in- P vestigated this issue, studying a racially diverse but socioeconomically homogeneous cohort of 215 patients with breast cancer at a New York public hospital from January 1, 1999, through December 31, 2003. We analyzed positive findings for estrogen, progesterone, and human epider- mal growth factor receptor 2 (HER2) (HER2/neu) receptors, considering patients in racial groups by cancer stage and overall. No difference was found in rates of estrogen, progesterone, or HER2/ neu positivity among Asian, black, Hispanic, or white patients presenting with ductal carcinoma in situ or with invasive cancer. Arch Surg. 2008;143(12):1227-1230 These patients represented all surgical pa- Breast cancer constitutes 18% of cancers tients with complete receptor data available. in women and is the second leading cause Rates of positivity for

Journal

JAMA SurgeryAmerican Medical Association

Published: Dec 1, 2008

References